Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Whitehawk Therapeutics (WHWK) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Whitehawk Therapeutics (WHWK) over the last 7 years, with Q3 2025 value amounting to 0.66%.

  • Whitehawk Therapeutics' Return on Capital Employed rose 1900.0% to 0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.8% for FY2024, which is 2600.0% down from last year.
  • Whitehawk Therapeutics' Return on Capital Employed amounted to 0.66% in Q3 2025, which was up 1900.0% from 0.52% recorded in Q2 2025.
  • Over the past 5 years, Whitehawk Therapeutics' Return on Capital Employed peaked at 0.04% during Q2 2021, and registered a low of 1.11% during Q4 2024.
  • Over the past 5 years, Whitehawk Therapeutics' median Return on Capital Employed value was 0.66% (recorded in 2023), while the average stood at 0.63%.
  • Per our database at Business Quant, Whitehawk Therapeutics' Return on Capital Employed crashed by -10700bps in 2022 and then surged by 6500bps in 2023.
  • Over the past 5 years, Whitehawk Therapeutics' Return on Capital Employed (Quarter) stood at 0.75% in 2021, then skyrocketed by 51bps to 0.37% in 2022, then plummeted by -78bps to 0.66% in 2023, then crashed by -69bps to 1.11% in 2024, then surged by 40bps to 0.66% in 2025.
  • Its Return on Capital Employed stands at 0.66% for Q3 2025, versus 0.52% for Q2 2025 and 0.45% for Q1 2025.